Altamira Therapeutics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CYTO research report →
About the company
Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharmaceutical nasal spray designed for individual protection against prevalent airborne viruses and allergens.
- CEO
- Thomas Meyer
- IPO
- 2014
- Employees
- 10
- HQ
- Hamilton, BM
Price Chart
- Market Cap
- $1.13M
- P/E
- -0.02
- P/S
- 0.00
- P/B
- 0.02
- EV/EBITDA
- -0.09
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -111.64%
- ROIC
- -77.74%
- Revenue
- $0 · 0.00%
- Net Income
- $-7,270,000 · 0.00%
- EPS
- $-14.81 · 0.00%
- Op Income
- $-5,916,000
- FCF YoY
- 45.99%
- 52W High
- $0.42
- 52W Low
- $0.30
- 50D MA
- $0.17
- 200D MA
- $0.60
- Beta
- 2.44
- Avg Volume
- 244.03K
Get TickerSpark's AI analysis on CYTO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 8, 08 | CARTER STEPHEN | sell | 10,000 |
| May 8, 08 | LOKAY KEVIN G | sell | 100,000 |
| May 8, 08 | LOKAY KEVIN G | sell | 185,439 |
| May 8, 08 | MOLLICA JOSEPH A | sell | 10,000 |
| Nov 13, 07 | LOKAY KEVIN G | other | 500,000 |
| Nov 13, 07 | LOKAY KEVIN G | other | 350,877 |
| Nov 13, 07 | LOKAY KEVIN G | other | 175,439 |
| Jun 14, 07 | LOKAY KEVIN G | other | 10,000 |
| Jun 13, 07 | LOKAY KEVIN G | other | 10,000 |
| Jun 14, 07 | MOLLICA JOSEPH A | other | 10,000 |
Our CYTO coverage
Recent articles, reports, and earnings notes.
No research on CYTO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CYTO report →Similar companies
Peers in the same neighborhood.